Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ProStat-64 is a concentrated liquid protein supplement designed for the dietary management of patients with increased protein requirements, such as those suffering from protein-energy malnutrition, pressure ulcers, or end-stage renal disease (ESRD) on hemodialysis. Developed by Medtrition, the product is formulated as a medical food that provides a high concentration of hydrolyzed collagen protein (typically 15 grams per 30 mL) in a low-volume dose, which is particularly beneficial for fluid-restricted patients. It is often fortified with specific amino acids to support nitrogen balance and improve nutritional markers like serum albumin and prealbumin. In clinical trials, it has been evaluated for its ability to maintain lean body mass and improve overall nutritional status in chronic dialysis populations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ProStat-64.